Regeneron Pharmaceuticals Aktie
481,60
EUR
+1,80
EUR
+0,38
%
564,00
USD
+8,47
USD
+1,52
%
Werbung
Regeneron Pharmaceuticals Aktie Analyse
20.10.17 | Regeneron Pharmaceuticals Underweight | Barclays Capital | |
01.08.17 | Regeneron Pharmaceuticals Underperform | Robert W. Baird & Co. Incorporated | |
07.11.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
16.03.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
25.01.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
05.08.15 | Regeneron Pharmaceuticals Sell | UBS AG | |
11.01.05 | Regeneron Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung